Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update

Forte Biosciences, Inc. (NASDAQ:FBRX) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 4,100 shares, a growth of 24.2% from the September 30th total of 3,300 shares. Based on an average trading volume of 9,600 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.3% of the company’s shares are sold short.

Forte Biosciences Trading Down 0.7 %

Forte Biosciences stock traded down $0.03 during midday trading on Wednesday, reaching $4.55. The company’s stock had a trading volume of 21,470 shares, compared to its average volume of 3,923. Forte Biosciences has a 52 week low of $4.44 and a 52 week high of $21.25. The business has a 50-day moving average price of $5.28 and a 200-day moving average price of $1.87. The stock has a market cap of $6.64 million, a PE ratio of -0.25 and a beta of 0.01.

Forte Biosciences (NASDAQ:FBRX) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.11). As a group, research analysts predict that Forte Biosciences will post -22.5 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Chardan Capital restated a “buy” rating and issued a $3.00 price objective on shares of Forte Biosciences in a research report on Monday, August 19th.

Forte Biosciences Company Profile

Forte Biosciences, Inc operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc is headquartered in Dallas, Texas.